Published May 22, 2015 | Version v1
Journal article

Effect of TGFβ on calcium signaling in megakaryocytes

  • 1. Department of Physiology I, University of Tübingen, Tübingen (Germany)
  • 2. Department of Pediatric Surgery and Pediatric Urology, University Children's Hospital Tübingen, Tübingen (Germany)
  • 3. Department of Cardiology & Cardiovascular Medicine, University of Tübingen, Tübingen (Germany)
  • 4. Department of Pharmacy, University of Tübingen, Tübingen (Germany)

Description

TGFβ is a powerful regulator of megakaryocyte maturation and platelet formation. As previously shown for other cell types, TGFβ may up-regulate the expression of the serum & glucocorticoid inducible kinase SGK1, an effect requiring p38 kinase. SGK1 has in turn recently been shown to participate in the regulation of cytosolic Ca2+ activity ([Ca2+]i) in megakaryocytes and platelets. SGK1 phosphorylates the IκB kinase (IKKα/β), which in turn phosphorylates the inhibitor protein IκBα resulting in nuclear translocation of nuclear factor NFκB. Genes up-regulated by NFκB include Orai1, the pore forming ion channel subunit accomplishing store operated Ca2+ entry (SOCE). The present study explored whether TGFβ influences Ca2+ signaling in megakaryocytes. [Ca2+]i was determined by Fura-2 fluorescence and SOCE from the increase of [Ca2+]i following re-addition of extracellular Ca2+ after store depletion by removal of extracellular Ca2+ and inhibition of the sarcoendoplasmatic Ca2+ ATPase (SERCA) with thapsigargin (1 μM). As a result, TGFβ (60 ng, 24 h) increased SOCE, an effect significantly blunted by p38 kinase inhibitor Skepinone-L (1 μM), SGK1 inhibitor EMD638683 (50 μM) and NFκB inhibitor wogonin (100 μM). In conclusion, TGFβ is a powerful regulator of store operated Ca2+ entry into megakaryocytes, an effect mediated by a signaling cascade involving p38 kinase, SGK1 and NFκB. - Highlights: • TGFβ up-regulates store operated Ca2+ entry (SOCE) in megakaryocytes. • The effect of TGFβ on SOCE is blunted by p38 kinase inhibitor Skepinone-L. • The effect of TGFβ on SOCE is virtually abrogated by SGK1 inhibitor EMD638683. • The effect of TGFβ on SOCE is almost abolished by NFκB inhibitor wogonin. • The effect of TGFβ is expected to enhance sensitivity of platelets to activation

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2015.03.159

Additional details

Identifiers

DOI
10.1016/j.bbrc.2015.03.159;
PII
S0006-291X(15)00627-0;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
461
Journal Issue
1
Journal Page Range
p. 8-13
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.